Honoring Kristen Oelschlager as a Leader in Arizona's Bioscience Community
Castle Biosciences, Inc. (Nasdaq: CSTL), known for its groundbreaking health tests, is excited to announce that Kristen Oelschlager, R.N., the company’s Chief Operating Officer, has been awarded the esteemed title of the 2024 Jon W. McGarity Arizona Bioscience Leader of the Year. This accolade, presented by the Arizona Bioindustry Association, Inc. (AZBio), marks a pivotal moment in Oelschlager's career, highlighting her outstanding leadership and contributions to the bioscience field.
Leadership That Makes a Difference
Kristen's unwavering commitment, insightful leadership, and dedication to healthcare are evident in her significant influence on Castle Biosciences. Derek Maetzold, the company’s president and CEO, praised her by stating, "Kristen’s tenacity and leadership have been crucial to our growth and workplace culture. Her focus on enhancing patient care propels our company forward. There is no one more deserving of this honor than her."
The recognition from AZBio not only reflects Oelschlager's professional achievements but also underscores her relentless drive to improve patient care. Joan Koerber-Walker, president and CEO of AZBio, shared, "Kristen’s career exemplifies her commitment to making a positive difference in patients’ lives, showcasing her vital role in advancements in disease management and patient care. We are delighted to recognize her as our 2024 Arizona Bioscience Leader of the Year."
Oelschlager's Journey with Castle Biosciences
Since she joined Castle Biosciences in 2008, Oelschlager has become a vital part of the company's entrepreneurial path alongside her dedicated colleagues. She has played a key role in developing innovative testing solutions for cancer patients, combining her expertise in clinical nursing, operations, and research to propel the company’s success. Her rich background supplies her with unique insights that continue to shape both the organization and the larger health industry landscape.
Notable Contributions to Patient Care
Throughout her extensive career, Oelschlager has prioritized improving care for patients, first as a nurse at the bedside and now in a broader capacity at Castle Biosciences. The advancements made under her leadership are transforming patient care models, not only in Arizona but extending further throughout the healthcare spectrum.
Castle Biosciences is dedicated to advancing science and providing patient support, featuring a wide range of diagnostic tests for various health issues, including skin cancers and mental health disorders. The company is focused on research and development, working on new strategies to address high clinical need diseases like atopic dermatitis and psoriasis.
Upcoming Celebration for Oelschlager
The Arizona life science community is preparing for a significant event set for September 18, 2024, at the Phoenix Convention Center, where the AZBio Awards will be held. During this ceremony, Kristen Oelschlager will be officially recognized and honored for her accomplishments and contributions to the industry.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is leading the diagnostics sector by using innovative testing methods to enhance patient care effectively. The company's people-first philosophy emphasizes the importance of patients, healthcare professionals, employees, and investors in its approach to disease management.
With an extensive portfolio of tests for various cancers, Barrett's esophagus, and mental health conditions, Castle is committed to making significant contributions to the community. Their ongoing research aims to develop additional tests that will improve treatment decisions in urgently needed medical areas.
Frequently Asked Questions
Who is Kristen Oelschlager?
Kristen Oelschlager serves as the Chief Operating Officer of Castle Biosciences and is recognized for her leadership and significant contributions to the bioscience field.
What award did Oelschlager receive?
She has been honored with the Jon W. McGarity Arizona Bioscience Leader of the Year award by the Arizona Bioindustry Association.
What is the main focus of Castle Biosciences?
Castle Biosciences is dedicated to creating innovative diagnostic tests that enhance patient care, particularly in oncology and other critical health areas.
When will the AZBio Awards take place?
The AZBio Awards are scheduled for September 18, 2024, at the Phoenix Convention Center.
Why is this recognition significant?
This award highlights Oelschlager's impact on the bioscience industry and her commitment to improving patient care both in Arizona and beyond.
